Adriacin suppresses cancer cell proliferation by forming a complex with cancer cell DNA and inhibiting DNA and RNA synthetase reactions. It is usually used to improve symptoms of malignant lymphoma, lung cancer, gastrointestinal cancer, breast cancer, bladder tumor, or bone sarcoma. This product can be used in anticancer activity research.
Molecular Weight
579.98
Molecular Formula
C27H29NO11·HCl
Form
Powder
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Stability
The product is stable for two years when stored at the recommended temperature.
Applications
Adriacin can be used in anticancer activity research.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.